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Abstract
Introduction Adrenal failure (AF) is associated with increased
mortality in septic patients. Nonetheless, there is no agreement
regarding the best diagnostic criteria for AF. We compared the
diagnosis of AF considering different baseline total cortisol
cutoff values and Δmax values after low (1 μg) and high (249 μg)
doses of corticotropin, we analyzed the impact of serum albumin
on AF identification and we correlated laboratorial AF with
norepinephrine removal.
Methods A prospective noninterventional study was performed
in an intensive care unit from May 2002 to May 2005, including
septic shock patients over 18 years old without previous steroid
usage. After measurement of serum albumin and baseline total
cortisol, the patients were sequentially submitted to 1 μg and
249 μg corticotropin tests with a 60-minute interval between
doses. Post-stimuli cortisol levels were drawn 60 minutes after
each test (cortisol 60 and cortisol 120). The cortisol 60 and
cortisol 120 values minus baseline were called Δmax1  and
Δmax249, respectively. Adrenal failure was defined as Δmax249 ≤
9 μg/dl or baseline cortisol ≤ 10 μg/dl. Other baseline cortisol
cutoff values referred to as AF in other studies (≤15, ≤20, ≤25
and ≤34 μg/dl) were compared with Δmax249 ≤ 9 μg/dl and
serum albumin influence. Norepinephrine removal was
compared with the baseline cortisol values and Δmax249 values.
Results We enrolled 102 patients (43 male). AF was diagnosed
in 22.5% (23/102). Patients with albumin ≤2.5 g/dl presented a
lower baseline total cortisol level (15.5 μg/dl vs 22.4 μg/dl, P =
0.04) and a higher frequency of baseline cortisol ≤25 μg/dl
(84% vs 58.3%, P = 0.05) than those with albumin > 2.5 g/dl.
The Δmax249 levels and Δmax249 ≤ 9, however, were not affected
by serum albumin (14.5 μg/dl vs 18.8 μg/dl, P = 0.48 and 24%
vs 25%, P = 1.0). Baseline cortisol ≤ 23.6 μg/dl was the most
accurate diagnostic threshold to determine norepinephrine
removal according to the receiver operating characteristic
curve.
Conclusion AF was identified in 22.5% of the studied
population. Since Δmax249 ≤ 9 μg/dl results were not affected by
serum albumin and since the baseline serum total cortisol varied
directly with albumin levels, we propose that Δmax249 ≤ 9 μg/dl,
which means Δmax after high corticotropin dose may be a better
option for AF diagnosis whenever measurement of free cortisol
is not available. Baseline cortisol ≤23.6 μg/dl was the best value
for predicting norepinephrine removal in patients without
corticosteroid treatment.
Introduction
Septic shock and multiple organ failure are the most frequent
causes of death in medical intensive care units (ICUs), and
were responsible for approximately 750,000 admissions and
210,000 deaths throughout 1995 in the USA [1]. Although
the mortality rate has been declining, the incidence of sepsis
has increased, resulting in almost three times the number of
sepsis-related deaths in the USA between 1979 and 2000
[2]. Furthermore, patients who survive sepsis have a worse
long-term health-related quality of life [3,4].
A normally functioning hypothalamic–pituitary–adrenal axis is
essential to organ homeostasis during acute illness, especially
in severe infections. Patients with adrenal failure (AF) and sep-
tic shock are known to present high mortality rates [5]. Addi-
tionally, stress doses of hydrocortisone have been shown to
AF = adrenal failure; Δmax = difference between the highest serum cortisol value after corticotropin stimulus and the baseline cortisol value; Δmax1= 
difference between serum cortisol value after low (1 μg) corticotropin dose and the baseline cortisol value; Δmax249= difference between serum cor-
tisol value after high (249 μg) corticotropin dose and the baseline cortisol value; ICU = intensive care unit.Critical Care    Vol 10 No 5    Salgado et al.
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reduce septic-shock-related mortality [6-8], mainly in patients
with an impaired response to the corticotropin test [9,10].
The incidence of AF may vary widely, from 0% to 77%,
depending on the studied population and the criteria used for
the diagnosis [11]. Although chronic AF (Addison disease) is
rare and relatively simple to identify, the acute presentation is
not straightforward and is usually unrecognized. A high suspi-
cion index is necessary since the classical clinical and labora-
torial findings, such as hypotension, fever, abdominal pain,
hypoglycemia, electrolyte abnormalities and eosinophilia, are
easily mistaken for the critically ill condition.
The failure of serum cortisol to rise above 18 or 20 μg/dl at 30
or 60 minutes after administration on 250 μg corticotropin is
classically considered diagnostic for adrenal failure in the
absence of acute illness [12]. There is, however, no consen-
sus on the best diagnostic criteria for AF in acutely ill patients.
Some authors recommend the use of baseline cortisol, justify-
ing that acute stress such as severe infections, surgery, shock
and hypoxemia are enough stimuli to the adrenal glands
[11,13,14]. Many cortisol cutoff values have been proposed,
ranging from 10 to 34 μg/dl, but most researchers consider a
baseline cortisol lower than 15 μg/dl to better identify patients
presenting clinical features of corticosteroid insufficiency or
those who would benefit from corticosteroid replacement
[15,16]. Conversely, other authors consider that it is possible,
by performing a low-dose (1 μg) [10] or mainly a high-dose
(250 μg) corticotropin test [9,17], to identify patients with rel-
ative adrenal insufficiency when the difference between the
highest serum cortisol value and the baseline cortisol value
(Δmax) is lower than 9 μg/dl [17,18]. Some of these authors
suggest these adrenal insufficiency patients could benefit
from corticosteroid treatment [9,10,17]. Additionally, because
more than 90% of circulating cortisol in human serum is bound
to proteins (corticosteroid binding protein and albumin), either
the baseline cortisol level or the Δmax value may be influenced
by serum protein levels, and alterations in the binding proteins
could affect the measured concentration of total serum corti-
sol [19-21].
The main aim of the present study was to compare the diagno-
sis of adrenal failure considering different baseline cortisol cut-
off values and the Δmax value after a low dose (1 μg) and a
high dose (249 μg) of corticotropin. Secondarily, we analyzed
the impact of serum albumin on AF identification and we cor-
related the laboratorial diagnosis of AF with norepinephrine
removal in patients with septic shock.
Patients and methods
Patients
This prospective and noninterventional study was carried out
in an ICU of a tertiary private hospital from May 2002 to May
2005. The Institutional Ethics Committee waived the need for
informed consent as the test is routinely performed in the unit.
We included patients over 18 years old admitted to the ICU
with septic shock, defined by the American College of Chest
Physicians/Society of Critical Care Medicine Conference
Consensus Committee [22] as the presence of two or more of
the following conditions as a result of infection: fever (temper-
ature >38°C) or hypothermia (temperature <36°C); tachycar-
dia (heart rate >90 beats/minute), tachypnoea (respiratory
rate >20 breaths/minute) or hyperventilation (partial pressure
of arterial blood CO2 <32 mmHg); altered white blood cell
count (>12,000 cells/mm3 or <4,000 cells/mm3 or >10%
band forms); and hypotension (mean arterial blood pressure
<65 mmHg) with vasopressor drug requirement (norepine-
phrine at any dose) despite adequate fluid resuscitation.
Exclusion criteria were corticosteroid usage in the past year or
its requirement as part of the treatment in the present admis-
sion, administration of etomidate, end-stage cancer, AIDS,
chronic renal failure requiring hemodialysis support, cirrhosis
(Child–Pugh class C), pregnancy, or limitation of lifecare sup-
port.
The presence of community-acquired infection was estab-
lished according to clinical, imaging and microbiological
parameters within 72 hours of ICU admission or hospital
admission. For nosocomial infection, the diagnosis was based
on the Centers for Disease Control criteria [23]. The infection
sources were classified as lung, urinary, abdominal or pelvic,
skin, vascular, and others.
General management
A pulmonary artery catheter or a central venous catheter and
an arterial line were placed in all patients. Norepinephrine was
used to maintain mean arterial blood pressure higher than 65
mmHg after adequate fluid resuscitation (central venous or
pulmonary artery occlusion pressure >12 mmHg) with either
crystalloids or colloids. Antibiotics were guided according to
institutional recommendations. The mechanical ventilation
strategy and the renal replacement therapy (continuous hemo-
filtration preferably) were in accordance with the Surviving
Sepsis Campaign [24]. All patients received deep venous
thrombosis prophylaxis and stress ulcer prophylaxis. Continu-
ous infusion of midazolam and fentanyl were given when nec-
essary. Hydrocortisone (100 mg intravenously three times per
day) therapy was not controlled and was administered at the
discretion of the attending physician.
Clinical evaluation
Patients were followed up to hospital discharge. The following
variables were recorded: age, gender, admission category
(trauma, medical or surgical), source of infection, and dates of
hospital admission and ICU admission; the Acute Physiology
and Chronic Health Evaluation II score [25] and the Simplified
Acute Physiology II score [26] on the first admission day, and
the Sequential Organ Failure Assessment [27] on days 1, 3, 5,
7, 10, 14, 18, 21, 24, 28, and 30 of ICU admission; the maxi-Available online http://ccforum.com/content/10/5/R149
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mum Sequential Organ Failure Assessment score during the
ICU stay [28]; the use of norepinephrine during the first five
days of hydrocortisone treatment or after the corticotropin test
when steroid was not given; and the hospital, ICU, and 28-day
mortality rates.
Corticotropin test and laboratory variables
All patients were submitted to a low-dose (1 μg) and a high-
dose (249 μg) corticotropin test (Synacthene; Novartis
Pharma Stein AG, Stein, Switzerland) within the septic shock
period, and analysis of serum cortisol was performed by radi-
oimmunoassay (Immulite; DPC Diagnostic Products, Los
Angeles, CA, USA). After measurement of the serum baseline
cortisol, the patients were sequentially submitted to 1 μg and
249 μg corticotropin tests with a 60-minute interval between
doses. Post-stimuli cortisol levels were drawn 60 minutes after
each test (cortisol 60 and cortisol 120). The cortisol 60 and
cortisol 120 values minus the baseline cortisol value were
called Δmax1 and Δmax249, respectively. Cortisol results were
available within 24 hours after testing. All patients were on
norepinephrine at the time of the test. Laboratorial adrenal fail-
ure was defined as Δmax249 ≤ 9 μg/dl or baseline cortisol ≤ 10
μg/dl. Clinical adrenal failure was defined as removal of nore-
pinephrine up to 120 hours after hydrocortisone treatment.
The different baseline cortisol cutoff values referred to as adre-
nal failure criteria in other studies (≤15, 20, 25 and 34 μg/dl),
as well as Δmax1 ≤ 9 μg/dl and Δmax249 ≤ 9 μg/dl, were ana-
lyzed concerning serum albumin levels ≤2.5 g/dl and >2.5 g/
dl.
At the onset of septic shock, blood and cultures from the site
of infection were obtained. The white blood cell count, the total
serum protein and albumin, and the C-reactive protein level
were measured on the corticotropin test day.
Statistical analysis
Statistical analyses were conducted using SPSS 10.0 statis-
tical package software (SPSS Incorporation, Chicago, IL,
USA). The results of continuous variables are expressed as the
median and interquartile range (25–75%). Nonparametric
tests were used (Mann–Whitney U test for two independent
samples, and Kruskal–Wallis H test for several independent
samples) after exclusion of a normal distribution of the data by
the Kolmogorov–Smirnov test. The chi-square test or Fisher's
exact test was applied for categorical variables when indi-
cated. Norepinephrine removal was estimated by the Kaplan–
Meier method and the results were compared between groups
with the log-rank test.
The baseline cortisol concentration, the most accurate predic-
tor of the hemodynamic response to corticosteroid treatment,
was determined by the area under the receiver operating char-
acteristic curve. Pearson or Spearman's correlation coeffi-
cients correlated continuous variables. The sensitivity and
specificity of each baseline cortisol cutoff value (≤15, 20, 25
and 34 μg/dl) and Δmax1 were determined using a concentra-
tion of Δmax249 ≤ 9 μg/dl as the reference method. Differences
were considered significant at P < 0.05.
Results
Patient characteristics
One hundred and two patients were included (59 female), with
a median age of 74 (62–82) years. The demographic and epi-
demiological data are presented in Table 1. The main types of
ICU admission were medical (n = 50) and postoperative (n =
47). Acute respiratory distress syndrome was diagnosed in 52
patients (51%), and the lung was the most frequent source of
infection. Despite the clinical septic shock diagnosis, only 69
patients (67.6%) yielded positive microbiological results, with
Gram-negative bacillus predominance. Bacteremia was
detected in 22 (21.6%) patients, and nosocomial infections
were as frequent as community infections. All patients were
receiving norepinephrine when the corticotropin test was per-
formed, and hydrocortisone was given to 71 patients during
the shock phase for a median of 9 (5–13) days. The 28-day,
ICU, and hospital mortality rates were 31.4%, 35.3%, and
45.1%, respectively.
Laboratorial evaluation of adrenal function
The median values of the baseline cortisol level, cortisol 60,
cortisol 120, Δmax1, and Δmax249 were 17.2 μg/dl, 25.4 μg/dl,
35.5  μg/dl, 8.2 μg/dl, and 16.6 μg/dl, respectively. The
median time for the corticotropin test was 2 (1–4) days after
ICU admission (Table 1). AF was identified in 23 patients
(22.5%) considering either Δmax249 ≤ 9 μg/dl or baseline cor-
tisol ≤ 10 μg/dl, but only four patients (3.9%) presented both
criteria.
There was a weak but a significant correlation between the
serum albumin and baseline cortisol values – the lower the
albumin levels, the lower the baseline cortisol value (R2 = 0.1,
P = 0.02). The same finding was observed for cortisol 60 (R2
= 0.15, P = 0.002) and for cortisol 120 (R2 = 0.1, P = 0.01).
Nonetheless, there was no correlation between serum albumin
and Δmax249 values (R2 = 0.02, P = 0.08). AF was identified
more frequently in hypoalbuminemic patients than in those
with near-normal serum albumin levels when considering the
baseline cortisol value as the diagnostic criterion, especially
for the cortisol cutoff value ≤ 25 μg/dl (P = 0.05). On the other
hand, the incidence of AF according to Δmax1 ≤ 9 μg/dl and,
mainly, Δmax249 ≤ 9 μg/dl criteria was not affected by serum
albumin levels (Table 2).
The use of different baseline cortisol cutoff values would have
shown different AF frequencies according to different cutoff
values if they were considered the only criteria, where the
higher the cortisol threshold, the higher the AF incidence. AF
defined by the baseline cortisol level was highly variable
(22.5–92.2%), which was contrary to that determined by theCritical Care    Vol 10 No 5    Salgado et al.
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Table 1
Clinical, biological and infection data of patients
Sex
Female 59 (57.8)
Male 43 (42.2)
Age (years) 74 (62–82)
Admission diagnoses
Postoperative 47 (46.1)
Medical 50 (49)
Trauma 5 (4.9)
Acute respiratory distress syndrome 52 (51)
Length of intensive care unit stay (days) 18 (12–27.3)
Length of hospital stay (days) 33 (19–85.3)
Days for corticotropin testa 2 (1–4)
Total serum protein (g/dl)b 4.7 (4.1–5.2)
Serum albumin (g/dl)b 2 (1.7–2.4)
White blood cells (cells/μl) 11,550 (8,275–16,500)
C-reactive protein (mg/dl) 16.3 (10.5–25)
Baseline cortisol levels (μg/dl) 17.2 (10.6–23.8)
Cortisol 60 (μg/dl) 25.4 (18.6–39.2)
Cortisol 120 (μg/dl) 35.5 (24.5–49.9)
Δmax1 (μg/dl) 8.2 (3.5–17.3)
Δmax249 (μg/dl) 16.6 (10–26)
Mean daily dose of norepinephrinec (μg/kg/minute) 0.13 (0.04–0.54)
Sequential Organ Failure Assessment score (corticotropin test day) 9 (7.8–11)
Maximum Sequential Organ Failure Assessment score 10 (9–13)Available online http://ccforum.com/content/10/5/R149
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First-day Sequential Organ Failure Assessment score 7 (4–10)
Acute Physiologic and Chronic Heath Evaluation II score 20 (17–23)
Simplified Acute Physiology II score 43.5 (36–52.3)
28-day mortality rate 32 (31.4)
Intensive care unit mortality rate 36 (35.3)
Hospital mortality rate 46 (45.1)
Site of infection
Intra-abdominal 28 (27.5)
Soft tissue abscess/cellulitis 3 (2.9)
Lung 58 (56.9)
Central nervous system 1 (1)
Urinary tract 10 (9.8)
Endovascular infection 2 (2)
Microorganismsd
Gram-negative bacillus 72 (61.6)
Gram-positive coccus 39 (33.3)
Fungus 6 (5.1)
Bacteremia 22 (21.6)
Type of infection
Community 51 (50)
Nosocomial 51 (50)
Data presented as n (%) or median (interquartile range). Cortisol units: 1 μg/dl = 27.6 nmol/l. Cortisol 60, serum cortisol level drawn 60 minutes 
after stimulus with 1 μg corticotropin; Cortisol 120, serum cortisol level drawn 60 minutes after stimulus with 249 μg corticotropin (120 minutes 
after serum baseline cortisol); Δmax1, cortisol 60 value minus the baseline cortisol level; Δmax249, cortisol 120 value minus the baseline cortisol 
level. aDifference between corticotropin test day and intensive care unit admission day. bProtein and albumin levels were not measured in 15 
patients. cMean daily dose of norepinephrine during the first five days after hydrocortisone usage or after the corticotropin test. dMicrobiological 
identification was obtained in 69 patients (67.6%).
Table 1 (Continued)
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traditional criteria of cortisol < 20 μg/dl after corticotropin
stimulus with a low does or a high dose (Figure 1).
The absolute values of Δmax1 and Δmax249 were well corre-
lated (R2 = 0.42, P = 0.00001). Δmax1 ≤ 9 μg/dl was the best
criterion to predict the presence of Δmax249 ≤ 9 μg/dl, present-
ing an odds ratio of 2.29 (95% confidence interval, 1.74–3; R
= 0.45, P < 0.00001).
Clinical evaluation of adrenal function
The dose of norepinephrine was higher in patients treated with
hydrocortisone than in nontreated patients on the day before
beginning steroid treatment (0.35 μg/kg/minute versus 0.13
μg/kg/minute, P = 0.03). It was impossible to determine a
baseline cortisol value, as well as Δmax1 and Δmax249 values,
which would best define norepinephrine removal in both the
general population and in the group of patients treated with
hydrocortisone. Nonetheless, in the nontreated group the area
under the receiver operating characteristic curve of baseline
cortisol was 0.81, and the cortisol value of 23.6 μg/dl was
associated with the highest sensitivity (0.83) and the highest
specificity (0.75) for norepinephrine removal during the first
five days after the corticotropin test. As a general finding, in the
nontreated group we observed that the higher the baseline
cortisol, the higher the mean dose of norepinephrine and the
lower the probability of norepinephrine weaning (Figure 2).
Discussion
In the present study we analyzed the diagnosis of AF in a het-
erogeneous group of patients with septic shock. AF failure
was identified more reliably by Δmax249 ≤ 9 μg/dl than by sev-
eral baseline cortisol cutoff values since serum albumin levels
directly affected the measurement of the serum total cortisol at
baseline and after low and high doses of corticotropin, as well
as the frequency of different baseline total cortisol cutoff val-
ues; however, serum albumin levels did not affect the meas-
urement of Δmax levels and the frequency of Δmax249 ≤ 9 μg/
dl. Additionally, in the group of patients not treated with hydro-
cortisone, the baseline serum total cortisol level was a prog-
nostic marker for vasopressor dependence – the higher the
baseline cortisol, the higher the norepinephrine requirement.
Serum albumin levels influenced cortisol measurement at
baseline and after low and high corticotropin doses. We
observed that the lower the serum albumin, the higher the inci-
dence of AF when considering the baseline cortisol cutoff
value as the diagnostic criterion, especially for the value of 25
μg/dl. In the context of reduced serum albumin levels, there-
fore, the incidence of AF could be overestimated. On the other
hand, this effect was not observed for Δmax1 and Δmax249 val-
ues, and AF diagnosis regarding Δmax249 ≤ 9 μg/dl was not
influenced by serum albumin levels. These findings highlight
the importance of measuring the adrenal gland reserve (Δmax)
Table 2
Adrenal function according to the serum albumin level
Albumin ≤ 2.5 g/dl (n = 75) Albumin > 2.5 g/dl (n = 12) P value
Baseline cortisol (μg/dl) 15.5 (10.4–23.4) 22.4 (15.5–26.7) 0.04*
Cortisol 60 (μg/dl) 23.5 (17.2–36.6) 40.3 (27–51.5) 0.009*
Cortisol 120 (μg/dl) 30.4 (23.2–46.7) 41.9 (33.1–54.9) 0.04*
Δmax1 (μg/dl) 6.9 (3.5–13.2) 13.2 (3.7–26.6) 0.24
Δmax249 (μg/dl) 14.5 (9.4–23.4) 18.8 (9.9–28.9) 0.48
Baseline cortisol ≤ 10 17 (22.7) 1 (8.3) 0.45
Baseline cortisol ≤ 15 37 (49.3) 3 (25) 0.12
Baseline cortisol ≤ 20 52 (69.3) 6 (50) 0.2
Baseline cortisol ≤ 23.6 58 (77.3) 6 (50) 0.07
Baseline cortisol ≤ 25 63 (84) 7 (58.3) 0.05*
Baseline cortisol ≤ 34 70 (93.3) 11 (91.7) 1.0
Δmax249 ≤ 9 18 (24) 3 (25) 1.0
Δmax1 ≤ 9 46 (61.3) 4 (33.3) 0.07
Data presented as n (%) or median (interquartile range). Protein and albumin levels were not measured in 15 patients. Cortisol units: 1 μg/dl = 
27.6 nmol/l. Cortisol 60, serum cortisol level drawn 60 minutes after stimulus with 1 μg corticotropin; Cortisol 120, serum cortisol level drawn 60 
minutes after stimulus with 249 μg corticotropin (120 minutes after serum baseline cortisol); Δmax1, cortisol 60 value minus the baseline cortisol 
level; Δmax249, cortisol 120 value minus the baseline cortisol level.Available online http://ccforum.com/content/10/5/R149
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and confirm the results of previous studies that used Δmax249
≤ 9 μg/dl as the diagnostic criterion for AF in critically ill
patients and hypoproteinemic patients [9,10,16,17].
Our data are in accordance with those of Hamrahian and col-
leagues [20], which also showed significant variation of the
baseline total cortisol level, but not of the free cortisol fraction,
in patients with near-normal and low serum albumin – suggest-
ing that measurement of free cortisol could be a more reliable
method than measurement of total cortisol for diagnosis of AF
in critical illness. We were unable to measure the free cortisol
level in the present work but we did find, similar to free cortisol,
that Δmax249 ≤ 9 μg/dl was not affected by serum albumin,
allowing it to be a diagnostic option in the setting of hypopro-
teinemia, where baseline total cortisol is susceptible to serum
albumin variations and free cortisol measurement is not availa-
ble.
There are some points to be considered favoring Δmax249 ≤ 9
μg/dl in comparison with the free cortisol dosage. First,
Δmax249 ≤ 9 μg/dl is easier to measure and produces faster
results with lower costs and more widespread availability in
the ICU compared with free cortisol measurement. Second,
although baseline total cortisol levels may overestimate AF in
comparison with the free cortisol fraction dosage, the meas-
urement of free cortisol is still not validated for the prognosis
and as a guide for diagnosis and treatment of hypothalamic–
pituitary–adrenal axis dysfunction in critically ill septic patients.
In a very recent review in the literature about current problems
when evaluating hypothalamic–pituitary–adrenal function, Ara-
fah [21] reported significant Δmax ≤ 9 μg/dl variation accord-
ing to serum albumin. This result was different from that found
in our study, and we can speculate that differences in the stud-
ied population and the time for performing the corticotropin
test might explain the distinct findings.
Several studies have shown the prognostic role of Δmax249 ≤
9 μg/dl as it enables the identification of a specific group of
patients with low adrenal reserve, also known as 'relative adre-
nal failure', who could benefit from steroid replacement
[5,9,10,17,29]. Annane and colleagues [9] demonstrated that
patients with septic shock nonresponsive to 250 μg cortico-
tropin (Δmax ≤ 9 μg/dl) had a greater dependence on vaso-
pressor therapy and a higher hospital mortality rate than those
responsive to corticotropin stimulation (Δmax > 9 μg/dl), and
that a seven day treatment combination of hydrocortisone and
fludrocortisone significantly reduced vasopressor depend-
ence and hospital risk of death. The same benefit of steroid
treatment, however, was not observed in the responders to the
corticotropin test (Δmax > 9 μg/dl). Besides the reliability of
Δmax249 ≤ 9 μg/dl for the diagnosis of adrenal insufficiency,
the measurement of Δmax249 also enabled the identification of
septic shock patients at a high risk of death who should
receive hydrocortisone, avoiding excessive use of steroids.
Alongside the problem concerning the direct effect of serum
albumin variation on total cortisol levels and consequently AF
diagnosis, the definition of AF based on baseline total cortisol
levels may be extremely variable according to the threshold
established. We found that the higher the cutoff value used,
the higher the incidence of adrenal insufficiency. This problem
was well explored by Bernard and colleagues [30], who tested
Figure 1
Adrenal failure diagnosis according to different criteria Adrenal failure diagnosis according to different criteria. The number of patients and the frequency of adrenal failure (AF) according to several base-
line cortisol cutoff values (≤10, ≤15, ≤20, ≤25, and ≤34 μg/dl), the classical ambulatory criteria considering serum cortisol ≤ 20 μg/dl after stimulus 
with corticotropin at low dose (cortisol 60) and at high dose (cortisol 120), and the presence of Δmax1 ≤ 9 μg/dl and Δmax249 ≤ 9 μg/dl. It is 
observed that the higher the baseline cortisol level, the higher the theoretical diagnosis of AF. The low-dose test classified more patients with AF 
than the high-dose test when we considered the classical criteria of total cortisol ≤ 20 μg/dl after stimulus. This same pattern was observed for Δmax 
after low (Δmax1 ≤ 9 μg/dl) and high (Δmax249 ≤ 9 μg/dl) corticotropin doses.Critical Care    Vol 10 No 5    Salgado et al.
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different criteria of adrenal insufficiency in a population of
patients with recent traumatic brain injury. They showed that
the incidence of adrenal insufficiency varied from 22% to
100% according to the diagnostic criteria, which was very
similar to our findings. In an attempt to solve the problem, Ara-
fah [21] correlated the levels of baseline serum total cortisol
and free cortisol in critically ill patients with low and near-nor-
mal serum albumin. The author proposed that in hypoalbu-
minemic subjects the normal total cortisol level should be ≥9.5
μg/dl at baseline and ≥15.5 μg/dl after the cosyntropin test.
These values corresponded to free cortisol concentrations of
1.8 μg/dl and 3.1 μg/dl, respectively, which is considered the
normal cortisol range in critical illness by the author. It seems
that such an approach is more appropriate and rational than
simply trying to establish a fixed diagnostic cutoff value that
neglects serum protein variations.
AF was detected in 23 patients (22.5%) when considering a
baseline cortisol level ≤ 10 μg/dl or Δmax249 ≤ 9 μg/dl. Only
four of these patients presented both criteria. This is in accord-
ance with the majority of the studies that have reported a wide
range of incidence varying from 0 to 77% depending on the
studied population and adrenal insufficiency diagnostic crite-
ria [5,10,11,13,20,21,31-34].
In the more homogeneous group of patients who did not
receive hydrocortisone replacement, it was possible to corre-
late the baseline serum total cortisol levels with vasopressor
dependence. Higher norepinephrine doses and greater nore-
pinephrine dependence were observed in patients with higher
baseline cortisol levels. The baseline cortisol value of 23.6 μg/
dl, which best discriminated individuals who were weaned
from norepinephrine, was very close to the value of 23.7 μg/dl
described by Marik and Zaloga [13]. Other authors have also
shown bad prognosis with increased baseline cortisol, corre-
lating the highest cortisol levels with the most severe illness
and the highest risk of mortality [5,13,35]. Since in our study
hydrocortisone therapy was not controlled, patient selection
bias might have occurred explaining why it was not possible to
determine a value of baseline cortisol, Δmax1, or Δmax249 that
could predict norepinephrine removal either in the general
population of the study or in the steroid patient group. Addi-
tionally, other problems related to the study design, such as
the relatively small sample size and the long period of the
study, could have contributed to difficult outcome analysis.
Conclusion
Our study showed that the incidence of AF was 22.5% in a
heterogeneous group of septic shock patients and that
Δmax249 ≤ 9 μg/dl may be a better option for AF diagnosis
whenever free cortisol measurement is not available, since
Δmax249 ≤ 9 μg/dl was not affected by serum albumin while the
baseline total cortisol levels and their cutoff values varied
directly according to albumin levels. As a potential result, the
use of the baseline total cortisol level for AF diagnosis could
lead to misleading classification and excessive steroid
replacement in the context of hypoproteinemia. In the group of
patients without hydrocortisone therapy, we found that a base-
line cortisol level ≤ 23.6 μg/dl was the best value to predict
norepinephrine removal.
Competing interests
The authors declare that they have no competing interests.
Figure 2
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